Home / Companies / VTRS / Catalysts / Page 2 Catalysts · VTRS · CIK 1792044 · page 2 of 2 VTRS catalysts and FDA events, page 2. Updated November 16, 2026 Snapshot 20261116T222116Z Built 2026-11-16 22:21 UTC
The next PDUFA date, the soonest catalysts with their source quotes and the latest FDA decisions are on VTRS PDUFA dates and upcoming catalysts . This page continues the list.
Past catalysts and FDA decisions (continued) Date Drug Company Event Indication Status Source August 14, 2019 Pretomanid (pretomanid) VTRS FDA approval — Approved openFDA Drugs@FDA August 6, 2019 Epzicom (abacavir sulfate; lamivudine) VTRS Complete Response Letter — CRL issued FDA Complete Response Letters June 6, 2019 Acetaminophen (acetaminophen) VTRS Complete Response Letter — CRL issued FDA Complete Response Letters November 9, 2018 Yupelri (revefenacin) VTRS FDA approval — Approved openFDA Drugs@FDA July 10, 2018 Vancomycin Hydrochloride (vancomycin) VTRS FDA approval — Approved openFDA Drugs@FDA June 4, 2018 Fulphila (pegfilgrastim-jmdb) VTRS FDA approval — Approved openFDA Drugs@FDA May 17, 2018 nda210605 VTRS Complete Response Letter — CRL issued FDA Complete Response Letters March 22, 2018 Symfi Lo (efavirenz; lamivudine; tenofovir disoproxil fumarate) VTRS FDA approval — Approved openFDA Drugs@FDA February 28, 2018 Cimduo (lamivudine; tenofovir disoproxil fumarate) VTRS FDA approval — Approved openFDA Drugs@FDA February 5, 2018 Symfi Lo (efavirenz; lamivudine; tenofovir disoproxil fumarate) VTRS FDA approval — Approved openFDA Drugs@FDA December 6, 2017 Acetaminophen (acetaminophen) VTRS Complete Response Letter — CRL issued FDA Complete Response Letters December 1, 2017 Ogivri (trastuzumab-dkst) VTRS FDA approval — Approved openFDA Drugs@FDA February 1, 2017 Acetaminophen (acetaminophen) VTRS Complete Response Letter — CRL issued FDA Complete Response Letters March 10, 2016 Acetaminophen (acetaminophen) VTRS Complete Response Letter — CRL issued FDA Complete Response Letters February 27, 2015 Acetaminophen (acetaminophen) VTRS Complete Response Letter — CRL issued FDA Complete Response Letters
FDA calendar PDUFA dates PDUFA calendar AdCom calendar FDA approvals today CRL tracker PDUFA outcomes dataset Indications Every catalyst is quoted from VTRS’s SEC filings, FDA records or ClinicalTrials.gov; each row links its primary source. Dates move; the linked filing is authoritative. Not investment advice.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.